Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 2
2017 14
2018 7
2019 1
2020 5
2021 10
2022 25
2023 28
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Sun F, Cheng Y, Wanchai V, Guo W, Mery D, Xu H, Gai D, Siegel E, Bailey C, Ashby C, Al Hadidi S, Schinke C, Thanendrarajan S, Ma Y, Yi Q, Orlowski RZ, Zangari M, van Rhee F, Janz S, Bishop G, Tricot G, Shaughnessy JD Jr, Zhan F. Sun F, et al. Among authors: al hadidi s. Nat Commun. 2024 Jan 19;15(1):615. doi: 10.1038/s41467-024-44873-4. Nat Commun. 2024. PMID: 38242888 Free PMC article.
Ibrutinib-induced cardiomyopathy.
Kyi HH, Zayed Y, Al Hadidi S. Kyi HH, et al. Among authors: al hadidi s. J Community Hosp Intern Med Perspect. 2019 Feb 11;9(1):50-52. doi: 10.1080/20009666.2018.1555432. eCollection 2019. J Community Hosp Intern Med Perspect. 2019. PMID: 30788077 Free PMC article.
Targeting GPRC5D in multiple myeloma.
Elemian S, Al Hadidi S. Elemian S, et al. Among authors: al hadidi s. Expert Rev Anticancer Ther. 2024 May;24(5):229-238. doi: 10.1080/14737140.2024.2343114. Epub 2024 Apr 16. Expert Rev Anticancer Ther. 2024. PMID: 38607646 Review.
Perspectives on the Treatment of Multiple Myeloma.
Rafae A, van Rhee F, Al Hadidi S. Rafae A, et al. Among authors: al hadidi s. Oncologist. 2024 Mar 4;29(3):200-212. doi: 10.1093/oncolo/oyad306. Oncologist. 2024. PMID: 37995307 Free PMC article. Review.
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.
Cheng Y, Sun F, Alapat DV, Wanchai V, Mery D, Guo W, Cao H, Zhu Y, Ashby C, Bauer MA, Nookaew I, Siegel ER, Ying J, Chen JR, Gai D, Peng B, Xu H, Bailey C, Al Hadidi S, Schinke C, Thanendrarajan S, Zangari M, Chesi M, Bergsagel PL, van Rhee F, Janz S, Tricot G, Shaughnessy JD Jr, Zhan F. Cheng Y, et al. Among authors: al hadidi s. Cell Rep Med. 2023 Oct 17;4(10):101214. doi: 10.1016/j.xcrm.2023.101214. Epub 2023 Oct 3. Cell Rep Med. 2023. PMID: 37794587 Free PMC article.
Pembrolizumab for the treatment of Hodgkin Lymphoma.
Al Hadidi SA, Lee HJ. Al Hadidi SA, et al. Expert Opin Biol Ther. 2020 Nov;20(11):1275-1282. doi: 10.1080/14712598.2020.1830056. Epub 2020 Oct 16. Expert Opin Biol Ther. 2020. PMID: 33006479 Review.
Thromboprophylaxis in multiple myeloma.
Thalambedu N, Al Hadidi S. Thalambedu N, et al. Among authors: al hadidi s. Leuk Lymphoma. 2022 Dec;63(12):2807-2815. doi: 10.1080/10428194.2022.2092856. Epub 2022 Jun 27. Leuk Lymphoma. 2022. PMID: 35759648
103 results